Soren Acquisition - Unit

Founder

Reliance Global

Rich Sparkle

Edesa Biotech

Palvella Therapeutics

Larimar Therapeutics

Grande

Clarivate

Vir Biotechnology

Algorhythm

SORNU

<p>On January 8, 2026, Soren Acquisition Corp completed its IPO, raising $253 million by selling 25.3 million units at $10 each. An additional 3.3 million units were sold through underwriters' over-allotment option, and a private sale of 5 million warrants raised $5 million. The proceeds are placed in a trust account for future business combinations, with an audited balance sheet reflecting the IPO proceeds.</p>

TradingView

Soren Acquisition Corp Completes Initial Public Offering

<p>Soren Acquisition Corp. has announced the release of its unqualified independent audit report regarding its balance sheet as of January 8, 2026. The audit was conducted by a PCAOB-registered public accounting firm, which has been the company's auditor since 2025. The full report is accessible via a provided link. This news brief was generated by Public Technologies and is for informational purposes only, not to be considered as financial, investment, or legal advice.</p>

Reuters

Soren Acquisition Corp. Announces Publication of Unqualified Independent Audit Report

Soren Acquisition - Unit(SORNU.US)

Soren Acquisition Corp Completes Initial Public Offering

Soren Acquisition Corp. Announces Publication of Unqualified Independent Audit Report